NCT07071090 - A Study of DC50292A Tablet in Patients With MTAP-deleted Advanced or Metastatic Solid Tumors | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2025

Primary Completion Date

January 1, 2028

Study Completion Date

January 1, 2028

Conditions

Solid Tumor Malignancies

Interventions

DRUG

DC50292A

DC50292A tablet

Trial Locations (8)

RECRUITING

Fujian Cancer Hospital, Fuzhou

RECRUITING

Sun Yat-Sen University Cancer Center, Guangzhou

RECRUITING

Guangxi Medical University Cancer Hospital, Nanning

RECRUITING

Harbin Medical University Cancer Hospital, Harbin

RECRUITING

Henan Cancer Hospital, Zhengzhou

RECRUITING

Hunan Cancer Hospital, Changsha

RECRUITING

Shandong Cancer Hospital, Jinan

RECRUITING

Sir Run Run Shaw Hospital, Hangzhou